Manning Anthony M.
Director at GLUE; Chief Scientific Officer at MOMENTA PHARMACEUTICALS INC
- Sold, on record
- $6.7M
- Dollars the filings state
- Form 4 sales
- 37
- Latest Jun 29, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- GLUEMonte Rosa Therapeutics, Inc.Director
- MOMENTA PHARMACEUTICALS INCChief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- MOMENTA PHARMACEUTICALS INC258,807 shares
- GLUE20,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MOMENTA PHARMACEUTICALS INCUnusualJun 12, 2020 2020
Sold 6,756 shares at $30.15 ($204k)
Manning Anthony M., Chief Scientific Officer
Sold 24.3% of holdings ($837k position)21,002 shares left8.6x usual sizeFiling
- 2 Form 4 sale MOMENTA PHARMACEUTICALS INCUnusualJun 30, 2020 +18 days
Sold 6,811 shares at $35.10 ($239k)
Manning Anthony M., Chief Scientific Officer
Sold 18.9% of holdings ($1.3M position)29,191 shares left6.7x usual sizeFiling
- 3 Form 4 sale MOMENTA PHARMACEUTICALS INCUnusualJul 20, 2020 +20 days
Sold 51,099 shares at $33.91 ($1.7M)
Manning Anthony M., Chief Scientific Officer
Sold 77.6% of holdings ($2.2M position)14,717 shares left41.4x usual sizeFiling
- 4 Form 4 sale MOMENTA PHARMACEUTICALS INCPlan not statedJul 21, 2020 +1 day
Sold 1,939 shares at $34.69 ($67k)
Manning Anthony M., Chief Scientific Officer
Sold 13.2% of holdings ($511k position)12,778 shares left1.4x usual sizeFiling
- 5 Form 4 sale MOMENTA PHARMACEUTICALS INCPlan not statedAug 10, 2020 +20 days
Sold 347 shares at $32.36 ($11k)
Manning Anthony M., Chief Scientific Officer
Sold 2.6% of holdings ($438k position)13,181 shares left0.2x usual sizeFiling
- 6 Form 4 sale MOMENTA PHARMACEUTICALS INCPlan not statedAug 13, 2020 +3 days
Sold 403 shares at $29.31 ($12k)
Manning Anthony M., Chief Scientific Officer
Sold 3.1% of holdings ($386k position)12,778 shares left0.3x usual sizeFiling
- 7 Form 4 sale GLUEUnusualMay 21, 2026 +2107 days
Sold 10,000 shares at $18.01 ($180k)
Manning Anthony M., Director
No 10b5-1 planSold 100% of holdings ($180k position)0 shares leftFirst sale on recordFiling
- 8 Form 4 sale GLUEUnusualJun 29, 2026 +39 days
Sold 10,000 shares at $23.11 ($231k)
Manning Anthony M., Director
No 10b5-1 planSold 100% of holdings ($231k position)0 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (37)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Jun 30, 2026 | GLUE | Director | Form 4 sale | 10,000 | $231k | 100.0% | Unusual | SEC |
| May 21, 2026 | May 22, 2026 | GLUE | Director | Form 4 sale | 10,000 | $180k | 100.0% | Unusual | SEC |
| Aug 13, 2020 | Aug 13, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 403 | $12k | 3.1% | Plan not stated | SEC |
| Aug 10, 2020 | Aug 11, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 347 | $11k | 2.6% | Plan not stated | SEC |
| Jul 21, 2020 | Jul 23, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 1,939 | $67k | 13.2% | Plan not stated | SEC |
| Jul 20, 2020 | Jul 21, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 51,099 | $1.7M | 77.6% | Unusual | SEC |
| Jun 30, 2020 | Jul 1, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 6,811 | $239k | 18.9% | Unusual | SEC |
| Jun 12, 2020 | Jun 15, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 6,756 | $204k | 24.3% | Unusual | SEC |
| May 11, 2020 | May 12, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 414 | $14k | 3.1% | Plan not stated | SEC |
| May 8, 2020 | May 11, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 336 | $11k | 2.5% | Plan not stated | SEC |
| Apr 21, 2020 | Apr 22, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 1,886 | $58k | 12.9% | Plan not stated | SEC |
| Apr 20, 2020 | Apr 21, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 1,614 | $47k | 9.9% | Plan not stated | SEC |
| Mar 6, 2020 | Mar 9, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 7,310 | $212k | 36.4% | Unusual | SEC |
| Feb 18, 2020 | Feb 20, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 16,459 | $536k | 76.5% | Unusual | SEC |
| Feb 13, 2020 | Feb 14, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 9,330 | $281k | 30.2% | Unusual | SEC |
| Feb 11, 2020 | Feb 12, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 112 | $4k | 1.9% | Plan not stated | SEC |
| Feb 10, 2020 | Feb 11, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 224 | $7k | 3.6% | Plan not stated | SEC |
| Jan 22, 2020 | Jan 24, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 2,265 | $66k | 29.4% | Unusual | SEC |
| Jan 21, 2020 | Jan 22, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 1,235 | $37k | 13.8% | Plan not stated | SEC |
| Jan 15, 2020 | Jan 17, 2020 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 29,114 | $828k | 84.2% | Unusual | SEC |
| Dec 24, 2019 | Dec 27, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 51,445 | $1M | 90.4% | Unusual | SEC |
| Nov 13, 2019 | Nov 14, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 619 | $10k | 10.2% | Plan not stated | SEC |
| Nov 12, 2019 | Nov 13, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 169 | $3k | 2.7% | Plan not stated | SEC |
| Nov 8, 2019 | Nov 12, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 8,757 | $140k | 58.4% | Unusual | SEC |
| Oct 18, 2019 | Oct 21, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 6,365 | $88k | 30.9% | Unusual | SEC |
| Oct 14, 2019 | Oct 16, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 787 | $11k | 10.6% | Unusual | SEC |
| Aug 12, 2019 | Aug 13, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 114 | $1k | 1.5% | Plan not stated | SEC |
| Aug 8, 2019 | Aug 9, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 221 | $3k | 2.9% | Plan not stated | SEC |
| Jun 20, 2019 | Jun 21, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 39,433 | $513k | 85.0% | Unusual | SEC |
| May 10, 2019 | May 14, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 114 | $2k | 0.2% | Plan not stated | SEC |
| May 8, 2019 | May 9, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 224 | $3k | 0.5% | Plan not stated | SEC |
| Feb 14, 2019 | Feb 19, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 4,449 | $58k | 5.5% | Unusual | SEC |
| Feb 13, 2019 | Feb 14, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 7,717 | $98k | 8.8% | Unusual | SEC |
| Feb 12, 2019 | Feb 13, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 133 | $2k | 0.2% | Plan not stated | SEC |
| Feb 8, 2019 | Feb 11, 2019 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 264 | $3k | 0.4% | Plan not stated | SEC |
| Nov 12, 2018 | Nov 14, 2018 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 113 | $1k | 0.2% | Plan not stated | SEC |
| Nov 8, 2018 | Nov 13, 2018 | MOMENTA PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 229 | $3k | 0.4% | Plan not stated | SEC |